Viewing Study NCT06302829



Ignite Creation Date: 2024-05-06 @ 8:14 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06302829
Status: RECRUITING
Last Update Posted: 2024-03-12
First Post: 2024-03-04

Brief Title: Comparison of IMES Versus DN on ATrPs of AC
Sponsor: Riphah International University
Organization: Riphah International University

Study Overview

Official Title: Comparison of Intramuscular Electrical Stimulation Versus Dry Needling on Active Trigger Points of Adhesive Capsulitis
Status: RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of our study to compare DN and IMES for pressure pain threshold ROM and the shoulder function in active trigger points with adhesive capsulitis This study will add to the growing body of knowledge that if these two techniques yield comparable outcomes and if one technique is superior to the other which should be the alternative of therapy Moreover it would add to the society as there are very limited researches done in Pakistan using needling for trigger points in adhesive capsulitis
Detailed Description: In literature review 2021 they were see the short-term effect of dry needling of myofascial trigger point in patient with adhesive capsulitis They conclude MTrPs with DN technique were improve pain ROM disability and PPT along with conventional physiotherapy management among patient with adhesive capsulitis In another study 2021 in their study they were see the effect of dry needling and muscle energy technique separately in patient suffering shoulder impingement syndrome on active trigger point of infraspinatus In their study they conclude dry needling is an effective treatment to treat the active trigger point in patient suffering from shoulder impingement syndrome In another study 2023 in their study they see impact of dry needling with electrical stimulation on pain and disability in patient with musculoskeletal shoulder pain They do the systemic review of 5 studies to see the beneficial effect of dry needling and IMES They conclude that the significant improvement in pain ROM and functional disability in patient with musculoskeletal shoulder pain In 2021 study in their study they were see the effect of Dry Needling with percutaneous electrical nerve stimulation in patient with Myofascial neck pain They were applying the dry needling on myofascial trigger point present in upper trapezius in patient with Myofascial neck pain They conclude that electric nerve stimulation will improve disability and pain intensity in patient with myofascial neck pain In another study 2021 in their study they see the effect of intramuscular stimulation along with dry needling in patient with adhesive capsulitis They target the shoulder girdle muscle and paraspinal muscle C3 to C7 They conclude that IMES and dry needling were improve pain ROM and functional disability in patient with adhesive capsulitis In another study 2021 in their study they were target the deltoid myofascial trigger point to improve pain they conclude that dry needling and IMES were enhance blood circulation and cervical and shoulder ROM in MTrPs patient IMES and dry needling according to literature review is an effective treatment to treat the trigger points present at various points in different musculoskeletal conditions It reduces the shoulder pain severity and upper limb disability by deactivating the active MTrPs and improve the shoulder ROM in patient with adhesive capsulitis Hence there is lack of evidence to allow conclusions to be drawn about the effectiveness of Dry needling when compared with intramuscular electrical stimulation for adhesive capsulitis in term of pressure pain threshold and shoulder function in active trigger points

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None